This report studies the Cyanocobalamin market, Cyanocobalamin is a man-made form of vitamin B12. Vitamin B12 is important for growth, cell reproduction, blood formation, and protein and tissue synthesis.
Cyanocobalamin is used to treat vitamin B12 deficiency in people with pernicious anemia and other conditions.
Scope of the Report:
The classification of Drugs for Cyanocobalamin includes Injection, Oral and Spray . The proportion of Injection in 2017 is about 68%, and the proportion of Oral in 2017 is about 32%.
The drugs for Cyanocobalamin is used to treat and prevent a lack of vitamin B12 that may be caused by any of the following: pernicious anemia (lack of a natural substance needed to absorb vitamin B12 from the intestine); certain diseases, infections, or medications that decrease the amount of vitamin B12 absorbed from food; or a vegan diet (strict vegetarian diet that does not allow any animal products, including dairy products and eggs).
Drugs for Cyanocobalamin is application in Hospital & Clinic and Pharmacy. The most of Oral is used in Pharmacy.
The worldwide market for Vitamin B12 (Cobalamin, Cyanocobalamin) is expected to grow at a CAGR of roughly 3.6% over the next five years, will reach 380 million US$ in 2024, from 310 million US$ in 2019, according to a new study.
This report focuses on the Vitamin B12 (Cobalamin, Cyanocobalamin) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Luitpold Pharmaceuticals
Luitpold Pharmaceuticals (Daiichi Sankyo)
Endo International
Bristol-Myers Squibb
Sanofi-Aventis
Jamieson
Teva (Actavis)
Merck
Mylan
Bayer HealthCare
Pfizer
ANGELINI
Biological E
CCEPCD
Huaxin Pharmaceutical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Cyanocobalamin Injection
Cyanocobalamin Oral
Cyanocobalamin Spray
Market Segment by Applications, can be divided into
Hospitals
Clinics
Others
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Vitamin B12 (Cobalamin, Cyanocobalamin) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Vitamin B12 (Cobalamin, Cyanocobalamin), with price, sales, revenue and global market share of Vitamin B12 (Cobalamin, Cyanocobalamin) in 2017 and 2018.
Chapter 3, the Vitamin B12 (Cobalamin, Cyanocobalamin) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vitamin B12 (Cobalamin, Cyanocobalamin) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Vitamin B12 (Cobalamin, Cyanocobalamin) market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Vitamin B12 (Cobalamin, Cyanocobalamin) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
